FDAnews Announces — Native Advertising: How Life Science Companies Can Keep the FTC and FDA Happy Webinar, March 31, 2016

Share Article

Native advertising is a hot topic these days for marketers, regulatory affairs and in-house counsels of life science companies. Join AGG partners, Anuj Desai and Alan Minsk for a one-hour webinar that focuses on the potential risks that native advertising poses for life science companies, and learn how to minimize those risks while continuing to engage in native advertising.

Native Advertising:
How Life Science Companies Can Keep the FTC and FDA Happy
March 31, 2016 — 12:00 p.m. – 1:00 p.m. ET
http://www.fdanews.com/nativeadvertising    

Native advertising is a hot topic these days for marketers, regulatory affairs and in-house counsels of life science companies.

With the increase of native advertising, both the FTC and the FDA are tightening up on enforcement.

According to the FTC, ads that are not conspicuous about their commercial nature may be viewed as unfair, which could invite a lawsuit on grounds of false advertising and unfair competition.

Join AGG partners, Anuj Desai — partner of the Intellectual Property Practice Team — and Alan Minsk — partner and leader of the Food and Drug Practice Team — for a one-hour webinar that focuses on the potential risks that native advertising poses for life science companies, and learn how to minimize those risks while continuing to engage in native advertising.

Attendees will learn the following:

  •     What native advertising is
  •     FTC’s current view on native ads
  •     Dos and Don’ts of a native ad campaign

Register today and learn how to keep the FTC and FDA happy about native advertising.

Meet the Presenters:
Anuj Desai is a partner in the Litigation Practice and Intellectual Property Team. Mr. Desai regularly appears in state and federal courts throughout the country, and he advises clients on dispute avoidance and dispute resolution in the areas of commercial and intellectual property litigation.

Alan G. Minsk is a partner and leader of the Food and Drug Practice Team. Mr. Minsk focuses his practice on advising pharmaceutical, biologic, medical device, cosmetic and food companies, on all legal and regulatory matters relating to the U.S. Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA).

Who Will Benefit:

  •     Medical affairs
  •     Regulatory compliance officers
  •     Regulatory Affairs
  •     Promotion review committee members
  •     PRC Coordination
  •     Labeling
  •     Legal Counsel
  •     Compliance
  •     Executive management
  •     Advertising and marketing managers

Webinar Details:
Native Advertising:
How Life Science Companies Can Keep the FTC and FDA Happy
March 31, 2016 — 12:00 p.m. – 1:00 p.m. ET
http://www.fdanews.com/nativeadvertising    

Tuition:
$287 per site

Easy Ways to Register:
Online:     http://www.fdanews.com/nativeadvertising
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website